| P2093 | author name string | Hamilton TC | |
| | Wilson C | |
| | Howlett DR | |
| | Buckingham RE | |
| | Mootoo S | |
| P2860 | cites work | Tolbutamide stimulation and inhibition of insulin release: studies of the underlying ionic mechanisms in isolated rat islets | Q72129897 |
| | Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells | Q28259615 |
| | The relaxant action of BRL 34915 in rat uterus | Q28338316 |
| | Studies on the anti-vasoconstrictor activity of BRL 34915 in spontaneously hypertensive rats; a comparison with nifedipine | Q35755332 |
| | Electrical and mechanical effects of BRL34915 in guinea-pig isolated trachealis | Q35887151 |
| | Direct measurements of increased free cytoplasmic Ca2+ in mouse pancreatic beta-cells following stimulation by hypoglycemic sulfonylureas | Q38351945 |
| | Indwelling catheters for direct recording of arterial blood pressure and intravenous injection of drugs in the conscious rat | Q39099443 |
| | Interaction of sulfonylurea with the pancreatic B-cell | Q40214406 |
| | Cyclic changes in potential and resistance of the beta-cell membrane induced by glucose in islets of Langerhans from mouse | Q40912320 |
| | The control of 86Rb efflux from rat isolated pancreatic islets by the sulphonylureas tolbutamide and glibenclamide | Q41743596 |
| | Effect of the K+ efflux stimulating vasodilator BRL 34915 on 86Rb+ efflux and spontaneous activity in guinea-pig portal vein | Q42133411 |
| | Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein | Q42567680 |
| | The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels | Q42568109 |
| | Inhibition by sulphonylureas of vasorelaxation induced by K+ channel activators in vitro | Q45097910 |
| | Glucose dependent K+-channels in pancreatic beta-cells are regulated by intracellular ATP. | Q54151640 |
| | Intracellular ATP directly blocks K+ channels in pancreatic B-cells | Q59072807 |
| | [Glibornuride, a new high-effective antidiabetic agent. Pharmacological and biochemical comparative studies in various animal species and animal experimental models] | Q67252732 |
| | BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models | Q68972082 |
| | The antidiabetic sulfonylurea glibenclamide is a potent blocker of the ATP-modulated K+ channel in insulin secreting cells | Q68998504 |
| | Mechanism of the stimulation of insulin release in vitro by HB 699, a benzoic acid derivative similar to the non-sulphonylurea moiety of glibenclamide | Q69972595 |
| | Opposite effects of tolbutamide and diazoxide on 86Rb+ fluxes and membrane potential in pancreatic B cells | Q70245055 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 57-64 | |
| P577 | publication date | 1989-05-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat. | |
| P478 | volume | 97 | |